Biosimilars And Beyond: Celltrion Aiming For $9bn Post Merger

Two-Phase Plan

 
• By Jung Won Shin
merger
Celltrion Group To Begin Merger Of Three Key Affiliates as it aligns pieces • Source: Shutterstock

More from South Korea

More from Focus On Asia